OBJECTIVES: To assess in patients with systemic sclerosis (SSc) the concentration of different subpopulations of circulating extracellular vesicles (EVs) and their association with the progression of interstitial lung disease (PF-ILD). METHODS: The prospective study included 59 SSc cases, 54% with interstitial lung disease (ILD). Plasma levels of EVs were analysed with flow cytometry and labelled as endothelial (EEVs), platelet (PEVs), leucocyte (LEVs), and EVs, expressing ICAM1, TF, or HMGB1. The presence of ILD was defined by HRCT. Lung functional tests were done every 3-6â¯months over a 3-year follow-up period. PF-ILD was defined as â¥10% decline of FVC % from baseline, or â¥5-9% along with a decline in DLCO of â¥15%. RESULTS: At baseline, 32/59 SSc patients had ILD, with a median disease duration of 3â¯years, and 38% were therapy naïve. In ILD patients, increased levels of all investigated EVs were found in respect to SSc patients without ILD (pâ¯<â¯0.05). Therapy naïve ILD cases had altered only ICAM1â¯+â¯EVs compared to treated (pâ¯<â¯0.05). Multivariate regression analysis (MR) showed an independent association of PEVs (OR 1.004, 95% CI 1.001-1.01) and ICAM1â¯+â¯EVs (OR 1.3, 95% CI 1.1-1.5) with ILD. During the follow-up period, 12/32 ILD patients developed PF-ILD, and in this group, the levels of all explored EVs were elevated compared to those without PF-ILD (pâ¯<â¯0.05). In an ROC analysis, all EVs showed a good ability to identify PF-ILD patients (pâ¯<â¯0.05). Cox MR confirmed the independent predictive value of ICAM1â¯+â¯EVs (HR 1.1, 95% CI 1.01-1.1) with SSc PF-ILD. CONCLUSION: Circulating EV levels are increased in SSc and correlate with ILD. In particular, ICAM1â¯+â¯EVs may be a novel biomarker of PF-ILD, identifying SSc patients at high risk of progression who may require early aggressive treatment. Based on our results, the role of EVs in the pathogenesis and progression of ILD should be investigated further.
Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis-a prospective cohort study.
循环细胞外囊泡作为系统性硬化症进行性间质性肺病的预测生物标志物——一项前瞻性队列研究
阅读:4
作者:Colic J, Pruner I, Damjanov N, Antovic J, Sefik-Bukilica M, Cerinic M Matucci, Antovic A
| 期刊: | Frontiers in Medicine | 影响因子: | 3.000 |
| 时间: | 2025 | 起止号: | 2025 Apr 30; 12:1594201 |
| doi: | 10.3389/fmed.2025.1594201 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
